Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Oklo Inc (OKLO) vs Tenet Healthcare Corporation (THC) Price & Performance

Tenet Healthcare CorporationTrade

Price performance (Past 24H)

Key statistics

Oklo Inc vs Tenet Healthcare Corporation — how do they compare? Oklo Inc trades at $34.59 (market cap $6.43B), while Tenet Healthcare Corporation trades at $261.41 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 3.3× Oklo Inc's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Oklo Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oklo Inc for 31 Days and Tenet Healthcare Corporation for 15 Days on average.

OKLOTHC
Market Cap
$6.43B$20.98B
Volume
16,238,368428,008
Sector
UtilitiesHealth
52-Week High
$174.14$280.77
52-Week Low
$34.57$161.37
Typical Hold Time
31 Days15 Days
Enterprise Value
$3.97B$32.06B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Oklo Inc

OKLO trades at $36.82, down 4.49% with bearish technical signals. The company shows no revenue in 2025 and negative net income of -$105.66M, with profitability metrics deeply negative. Recent earnings have missed expectations in two of the last three quarters. However, analyst sentiment remains strong with 71% buy ratings and a $78.63 consensus price target, reflecting optimism about the nuclear energy opportunity.

The outlook balances high growth potential in the nuclear sector against significant execution risks. While the $10 trillion nuclear opportunity and partnerships with hyperscalers provide upside, OKLO faces challenges including negative cash flow from operations, substantial dilution from recent stock sales, and intense competition in the small modular reactor market.

Tenet Healthcare Corporation

Tenet Healthcare (THC) trades at $259.83, up 0.53% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 53.31%, net margin 9.9%). Recent news highlights strong cash flow supporting capital returns and upcoming Q3 2026 results on October 29. Valuation appears reasonable with P/E of 10.07 and EV/EBITDA of 5.75.

THC presents a compelling investment case with strong analyst support (81% buy ratings) and 7% upside to consensus target of $283.36. Key catalysts include sustained earnings momentum and efficient capital allocation. Risks include surgical volume pressures and cash flow sustainability concerns amid aggressive buybacks. The stock's current technical setup near pivot point $259 suggests balanced risk-reward.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

OKLO
89% Buy11% Sell
Avg holding period · 31 Days
THC

No sentiment data available yet.

Top news

Latest headlines on both assets

About Oklo Inc

Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.

Read more on OKLO →

About Tenet Healthcare Corporation

Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.

Read more on THC →